BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3301500)

  • 1. [Hypotensive efficacy of verapamil alone and in combination with a diuretic in the treatment of essential hypertension in geriatric patients].
    Latini R; Pierandrei G; Achilli L; Lombi V; D'Amico F
    G Ital Cardiol; 1987 Feb; 17(2):144-8. PubMed ID: 3301500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schriger A
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the efficacy and tolerability of sustained-release verapamil and captopril in mild to moderate essential arterial hypertension].
    Maarek-Charbit M; Stephan D; Welsch M; Galey-Arcangioli C; Imbs JL
    Ann Cardiol Angeiol (Paris); 1991 Oct; 40(8):509-13. PubMed ID: 1759789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of cadralazine or chlorthalidone in verapamil-treated elderly hypertensives.
    Antonicelli R; Savonitto S; Tomassini PF; Gambini C; Sardina M; Paciaroni E
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):198-203. PubMed ID: 8032580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
    Leonetti G; Pasotti C; Capra A
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):43-7. PubMed ID: 3514487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
    Weir MR; Cassidy CA; Hall PS; Lancaster A; Schubert C; Urick A; Saunders E; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1990; 12(2):139-48. PubMed ID: 2354483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of verapamil, captopril and their combination at rest and during dynamic exercise.
    Di Somma S; Petitto M; Liguori V; Carotenuto A; Paulucci A; De Divitiis O
    Arzneimittelforschung; 1992 Feb; 42(2):103-7. PubMed ID: 1610414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive efficacy of sustained-release verapamil.
    Zachariah PK; Sheps SG; Oshrain C; Schirger A; Stein WJ
    J Clin Hypertens; 1987 Dec; 3(4):536-46. PubMed ID: 3330987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions.
    Lenz ML; Pool JL; Laddu AR; Varghese A; Johnston W; Taylor AA
    Am J Hypertens; 1995 Feb; 8(2):133-45. PubMed ID: 7755941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
    Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
    Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sustained-released verapamil and ambulatory recording of blood pressure in mild to moderate essential hypertension].
    Bernadet P; Suc JM; Durand D; Galey C; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1992 Feb; 41(2):105-12. PubMed ID: 1562157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the angiotensin converting enzyme inhibitor enalapril compared with diuretic therapy in elderly hypertensive patients.
    Verza M; Cacciapuoti F; Spiezia R; D'Avino M; Arpino G; D'Errico S; Sepe J; Varricchio M
    J Hypertens Suppl; 1988 Nov; 6(1):S97-9. PubMed ID: 2851039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day].
    Fariello R; Alicandri C; Boni E; Montini E; Zaninelli A; Agabiti-Rosei E; Motolese M; Muiesan G
    G Ital Cardiol; 1984 Feb; 14(2):121-6. PubMed ID: 6714549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of verapamil and captopril in the treatment of essential hypertension.
    Heagerty AM; Swales JD
    Pharmatherapeutica; 1987; 5(1):21-5. PubMed ID: 3299395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term antihypertensive efficacy of ketanserin plus chlorthalidone.
    Fasano ML; Soro S; Ferrara LA
    Drugs Exp Clin Res; 1989; 15(11-12):587-90. PubMed ID: 2700322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Slow-release verapamil 240 mg and treatment of mild to moderate hypertension].
    Amabile G; Hulin P; Wajman A; Serradimigni A; Bory M
    Therapie; 1989; 44(4):275-8. PubMed ID: 2595646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.
    Fogari R; Zoppi A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):386-93. PubMed ID: 6469428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.